Blood thinner may stop organ failure in pancreatitis patients

NCT ID NCT07609771

Not yet recruiting Disease control Sponsor: Allied Hospital Faisalabad Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study tests whether giving the blood thinner heparin early can prevent organ failure in people hospitalized with acute pancreatitis. The inflammation from pancreatitis can cause tiny blood clots that damage organs like the lungs and kidneys. Half of the 100 participants will get standard care plus heparin, while the other half gets standard care alone. The main goal is to see if fewer people on heparin develop organ failure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Unfractionated heparin (a blood thinner)
What this could lead to: If it works, this could provide a simple, low-cost way to prevent life-threatening organ failure in acute pancreatitis, reducing deaths and hospital stays.
What could go wrong: This is a small, early-phase trial with only 100 patients. Heparin carries a risk of serious bleeding, and the benefit is unproven. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute pancreatitis pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE PANCREATITIS (AP)

Contacts and locations

Locations

Allied Hospital, Faisalabad

Faisalābad, Punjab Province, 38000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.